Phillip J. Sanchez
5Patents
3h-index
2Co-inventors
39Inventor score
Filing activity: May 3, 2007 → Jul 1, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7993648B2 | Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody | Emerging Cross-Sectional Technologies | 12 | Active |
| US8361471B2 | Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody | Emerging Cross-Sectional Technologies | 3 | Active |
| US8137672B2 | Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody | Emerging Cross-Sectional Technologies | 3 | Active |
| US9095608B2 | Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody | Emerging Cross-Sectional Technologies | 0 | Active |
| US10329338B2 | Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.